CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 130 enrolled
Drug / intervention
Acupuncture +2 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00545623
NCT00545623Phase 2Completed
CompareCT.gov

Acupuncture and Relaxation Response for GI Symptoms and HIV Medication Adherence

Boston University·interventional·Posted Oct 17, 2007·Updated Sep 3, 2014

In Brief

A Phase 2 clinical trial evaluating Acupuncture, Relaxation Response, and 1 other intervention for HIV Infections. Completed, enrolled 130 participants across 1 site.

Detailed Summary

The aims of the study are to investigate individual, combined and added effects of acupuncture and the relaxation response in reducing gastrointestinal symptoms, improving medication adherence and quality of life among people living with HIV/AIDS. The study will also explore the mechanism of these therapeutic effects of acupuncture and the relaxation response.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Infections
CountriesUnited States
CollaboratorsNational Center for Complementary and Integrative Health (NCCIH)

Timeline

Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 17, 2007
Enrollment StartApr 1, 2007
Primary CompletionSep 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 18.7 years ago

Interventions

Acupunctureprocedure

acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks

Relaxation Responsebehavioral

listening to CDs with verbal instructions of techniques to elicit relaxation response

sham acupunctureother

sham acupuncture twice/week for the first 4 weeks and once/week for another 4 weeks